Subgroup Could Give Xpovio Focused Commercial Opportunity In Endometrial Cancer

 
• By Alaric DeArment
  
Digital illustration of Cancer cell in colour background
Karyopharm announced topline results from its Phase III SIENDO trial in endometrial cancer • Source: Shutterstock

More from Anticancer

More from Therapy Areas